A Head-to-Head Comparison of Untargeted Metabolomics
Terms like “comprehensive coverage” and “untargeted detection” are widely used in metabolomics, but they are rarely evaluated in controlled comparisons. Panome Bio conducted a head-to-head study against a widely used legacy platform using identical samples,...
Untargeted Metabolomics: Legacy vs. Panome Bio
Researchers run experiments, send samples, and receive results that appear complete. However, a significant portion of the metabolome may never be captured in the final dataset. Not due to sample quality or preparation, but because many metabolomics platforms are...
Why Disease Risk Lives in the Exposome
For 20 years, genomics has promised precision medicine. And it delivered. For rare diseases and select cancers. But for most chronic conditions? Genetics explains only a fraction of risk. Type 2 diabetes. Alzheimer’s disease. Autoimmune disorders. Metabolic syndrome....